Clinical trials recruiting in Subang Jaya, Malaysia

Phase breakdown

Conditions recruiting in Subang Jaya, Malaysia

Recruiting trials in Subang Jaya, Malaysia

• A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
  NCT05457283 · Phase: Phase 3 · Ages: 1 Year to 18 Years · Sex: All (male and female)
• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
  NCT06452277 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
  NCT06765109 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Promoting Mental Health Among At-risk Adolescents in Malaysia
  NCT07138664 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 14 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Subang Jaya, Malaysia?

4 recruiting trials have at least one study site in Subang Jaya, Malaysia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.